IGNT!!! - Ingen Technologies news

[arlbbcrc29]

YUCAIPA, Calif., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT (http://finance.yahoo.com/q;_ylt=AiXRIM4zsM.A0RK5Buqp14b8ba9_;_ylu=X3oDMTB2d XZkZnFhBHBvcwMxBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA2lnbnQ-?s=ignt.pk) - News (http://finance.yahoo.com/q/h;_ylt=Anl_pdyl5NxFWvR4lLgb0Bf8ba9_;_ylu=X3oDMTB2M WIxcnJxBHBvcwMyBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA25ld3M-?s=ignt.pk)), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the Company has signed contracts with Emergo Group, Inc. to debut the Oxyview Nasal Cannula at the world's largest healthcare exhibitions.

[asonisgeyo]

On November 18, 2009, Emergo Group will introduce the new Oxyview Nasal Cannula at MEDICA in Germany. MEDICA is the center of attraction for all those involved in the health care industry. More than 135,000 visitors from well over 100 countries are expected to again obtain information on all the current and future trends in in-patient and out-patient care at this annual event. With its extensive ancillary program, numerous special events, two major congresses and the largest product display in the industry, MEDICA is the hub of the medical trade.


Next, on January 25, 2010, the Emergo Group will introduce the new Oxyview Nasal Cannula at Arab Health. The Arab Health Exhibition & Congress is the largest healthcare exhibition in the Middle East, and the second largest in the world. Arab Health is viewed as a must-attend global event in the healthcare calendar. Established 35 years ago, it provides a platform for the world's leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and beyond.


Emergo is currently assisting Ingen with the development and implementation of an ISO 13485 quality management system which is a requirement for China, Japan, Canada and Europe. In addition to Europe (CE Marking), Emergo is compiling Ingen's Technical File and have been contracted to be the company's European Authorized Representative. This CE Certificate will allow Ingen to sell all European countries where CE Marking is mandatory, i.e. 31 countries to date. The CE Marking is the company's ticket to all of these countries and no other additional registrations are required accept for Italy which requires device notification for all devices placed on the Italian market.

[auwoxyooifsu]

YUCAIPA, Calif., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT (http://finance.yahoo.com/q;_ylt=Ammd8MYgZZ.VT9kEdtMFKA38ba9_;_ylu=X3oDMTB2d XZkZnFhBHBvcwMxBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA2lnbnQ-?s=ignt.pk) - News (http://finance.yahoo.com/q/h;_ylt=AjvjrJUkl0UKCuEULC.I.lL8ba9_;_ylu=X3oDMTB2M WIxcnJxBHBvcwMyBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA25ld3M-?s=ignt.pk)), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that Today's Senior Magazine October issue was distributed to 180,000 seniors in California and Texas combined.

[Avrelyolert]

The Company has a full-page editorial and a full-page color advertisement of the new Oxyview Nasal Cannula in the October 2009 issue of Today's Senior Magazine. Today's Senior Magazine -- a senior magazine that provides important information, plus local and national products and services for people fifty and over, is one of the most read and talked about senior publications in California and Texas.


The Company is prepared to manufacture another 100,000 Oxyview Nasal Cannulas and has recently sold 50,000 Oxyview Nasal Cannulas in the past 60 days. "The patients have shown that they want the new Oxyview Nasal Cannula. Our inventory is well stocked, and we have worked out the bugs in our shipping and receiving while we maintain FDA and ISO compliance," stated Scott R. Sand, Chief Executive Officer and Chairman. Sand further stated, "Our engineering and management team are reviewing our manufacturing processes to meet projected annual inventory of 15M Oxyview Nasal Cannulas or approximately $86M in product sales. This is not unrealistic when you consider how Ingen has positioned the product, secured patents and intellectual property and has brought in the right groups to move product into the USA and globally."

[bnelkdni49]

YUCAIPA, Calif., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT (http://finance.yahoo.com/q;_ylt=AqryNjQyH5yQlBftAYbcIGb8ba9_;_ylu=X3oDMTB2d XZkZnFhBHBvcwMxBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA2lnbnQ-?s=ignt.pk) - News (http://finance.yahoo.com/q/h;_ylt=Ai8qKcGvADL6dc4hdG8dsT38ba9_;_ylu=X3oDMTB2M WIxcnJxBHBvcwMyBHNlYwNuZXdzQXJ0U3RhcnQEc2xrA25ld3M-?s=ignt.pk)), a leading Global Medical Device manufacturer focused in the $ 4 Billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries announced today that the company has signed a national 5 month campaign with The Money Channel and American Scene Radio program to reach millions of wealthy investors.